http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022254446-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09ef82d2688ed9862f3fad132f076e73 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 2022-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e38316ddd0844a74eea63172a4ed5ec3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aa2d7ecedce88b1089c3491a5cac11c |
| publicationDate | 2022-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022254446-A1 |
| titleOfInvention | Method for the treatment of microbial overgrowth, imbalance and infections |
| abstract | The present invention is directed to a method for treating and/or preventing skin, mucosal and systemic conditions resulting from microbial overgrowth, imbalance or infections comprising administering a composition to a mammalian subject, wherein said composition comprises oil obtained from Nigella sativa seeds, and wherein said oil comprises thymoquinone at a concentration of at least 2.5% w/w and one or more free fatty acids (FFAs) at a concentration of 2.5% w/w or less. The present invention is also directed to dosage forms comprising the aforementioned composition. |
| priorityDate | 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.